Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Biomaterials. 2018 Feb 6;163:67–75. doi: 10.1016/j.biomaterials.2018.01.035

Fig. 6.

Fig. 6

Tumor growth curves in controls and STINGel treated animals (n=10 per treatment group). (A) Median primary tumor growth for each group, showing significantly smaller median tumor size in CDN treated groups and a complete delayed growth in STINGel (MDP+CDN) C57BL/6 mice. (B–G) Individual tumor size growth data for tumor bearing mice in each group (number of tumor bearing mice above each plot), showing a clear improvement in progressive tumor free survival for the STINGel treated mice relative to controls and collagen+CDN. (B) HBSS, (C) CDN-alone, (D) MDP gel, (E) collagen gel, (F) collagen+CDN, (G) STINGel.